An official website of the United States government
Clinical Trial of Approaches to Prostate Cancer Surgery
Trial Status: active
This is a prospective, randomized controlled trial to compare cancer control and
health-related quality of life following pelvic fascia-sparing radical prostatectomy
versus standard radical prostatectomy.
The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have
similar cancer control (primary outcome) and sexual function outcomes; and significantly
better urinary function, penile shortening/deformity and inguinal hernia risks as
compared to radical prostatectomy.
Inclusion Criteria
Male sex
Age ≥40 years or ≤80 years
Scheduled for radical prostatectomy for clinically localized prostate cancer
Able to read and speak English or Spanish
Willingness to sign informed consent and adhere to the study protocol
Exclusion Criteria
Prior major pelvic surgery or radiotherapy
Suspicion of N1 disease (i.e., any lymph node greater than 1cm in maximal diameter)
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05155501.
Locations matching your search criteria
United States
California
Duarte
City of Hope Comprehensive Cancer Center
Status: Active
Name Not Available
District of Columbia
Washington
MedStar Georgetown University Hospital
Status: Active
Name Not Available
Illinois
Chicago
Northwestern University
Status: Active
Name Not Available
Massachusetts
Boston
Beth Israel Deaconess Medical Center
Status: Active
Name Not Available
Traditional radical prostatectomy is the most popular treatment for clinically
significant prostate cancer, however significant risks including urinary incontinence,
